Berlin, Germany

Wolf-Dieter Schleuning

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Berlin, MX (1998)
  • Berlin, DE (1998 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Wolf-Dieter Schleuning

Introduction

Wolf-Dieter Schleuning is a notable inventor based in Berlin, Germany. With a portfolio of six patents, he has made significant contributions to medical science, particularly in the treatment of strokes and cardiac conditions. His innovative approaches have the potential to change therapeutic practices in these critical areas.

Latest Patents

Among his latest inventions, Schleuning has developed a method involving non-neurotoxic plasminogen activating factors aimed at treating strokes in humans. This invention offers a new therapeutic concept intended to enhance treatment outcomes for stroke patients. Additionally, he has created a plasminogen activator derived from the saliva of the vampire bat. This novel thrombolytic agent is designed to dissolve blood clots within the human body, proving beneficial for conditions such as cardiac infarctions.

Career Highlights

Throughout his career, Wolf-Dieter Schleuning has worked for renowned organizations including Schering Aktiengesellschaft and Cancerforskningsfondet Af 1989. His experience in these institutions has enriched his expertise in research and innovation.

Collaborations

In his journey as an inventor, Schleuning has collaborated with several distinguished colleagues, including Bernard Jacques Haendler and Alejandro Alagon. Their collective knowledge and expertise have played a vital role in advancing his inventions.

Conclusion

Wolf-Dieter Schleuning's contributions to the field of medical science through his innovative patents exemplify the spirit of invention that propels advancements in healthcare. His work continues to inspire fellow inventors and researchers striving to improve therapeutic interventions for critical illnesses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…